Sleep disorders or Somnipathy is a medical conditions that affect the sleep pattern of a person on a regular basis. Some sleep disorders are so serious that they may interfere with normal physical, mental, social and emotional functioning. Most people experience sleeping problems due to stress, busy schedule and other outside influences. Sleep problems including sleep apnea, insomnia, sleep deprivation, restless legs syndrome are common.
The U.S. sleep disorder market was worth an estimated $28.6 billion in 2017. For 2018, the market should grow by 3.3%. In 2023, 4.7% average annual growth is estimated. The major prescription insomnia drugs sales total about $1.4 billion, led by Belsomra, Ambien, and Lunesta, has been declining in value due to the expiration of patents and the entry of cheaper generics. However, the non-prescription or OTC sleeping pills market, valued at $576 million, is growing faster. The global sleep disorders market can be divided into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. In terms of revenue in 2016, North America accounted for the maximum share of the global market and the trend is anticipated to continue during the forecast period. Strong growth of the market in the region can be ascribed to well-established health care infrastructure, awareness among people, and increase in the prevalence of sleep disorders. Europe is forecasted to be the second leading market for sleep disorders. However, slow growth of the economy in the region is likely to negatively impact the market. Asia Pacific market is anticipated to register a significantly high CAGR, owing to factors such as increasing patient population and growing government focus on enhancing health care facilities in the region.
Psychiatrists, Psychologists Neurologists, Neurosurgeons, Research scientists, Neurology Organizations, Pharmaceutical companies, Neuro and CNS drug Industries, Neuroscience associations, Professors, Students from Academia in the study of Sleep Disorders
Classification of sleep disorders, Risk , Treatment and Therapies, Pediatric sleep disorders, Psychiatric disorder and sleep, Obstructive sleep Apnea, Sleep Paralysis, Restless leg syndrome, Stress and depression, Neuropsychology, Sleep Medicine.
68 Quai de la Seine, 75019 Paris, France